How many drugs treat Fusospirochetal pharyngitis?

Drug Landscape tracks 5 marketed treatments for Fusospirochetal pharyngitis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/fusospirochetal-pharyngitis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Fusospirochetal pharyngitis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fusospirochetal pharyngitis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Fusospirochetal pharyngitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Minocycline Hydrochloride	MINOCYCLINE	Rempex	Tetracycline-class Drug		1971-01-01
Penicillin G Potassium In Plastic Container	Benzylpenicillin	Pfizer	Penicillin-class Antibacterial		1947-01-01
penicillin	penicillin	Karlstad University		Bacterial penicillin-binding protein, Beta-lactamase, Beta-lactamase TEM
Phenoxymethylpenicillin	Phenoxymethylpenicillin	Katarina Hedin		Bacterial penicillin-binding protein, Penicillin-binding protein 1A
Minocyclin	Minocyclin	University of Southern California		30S ribosomal protein S4, 30S ribosomal protein S9, Tetracycline resistance protein, class B

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Karlstad University · 1 drug in Fusospirochetal pharyngitis
Katarina Hedin · 1 drug in Fusospirochetal pharyngitis
Pfizer · 1 drug in Fusospirochetal pharyngitis
Rempex · 1 drug in Fusospirochetal pharyngitis
University of Southern California · 1 drug in Fusospirochetal pharyngitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Fusospirochetal pharyngitis:

Cite this brief

Drug Landscape (2026). Fusospirochetal pharyngitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/fusospirochetal-pharyngitis. Accessed 2026-06-10.

Fusospirochetal pharyngitis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing